Antilipemic Drugs and the Position of the FDA
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 26)
The U.S. Food and Drug Administration is charged with the responsibility of assuring safety and efficacy of marketed drugs and safe conditions for clinical investigation of drugs.
KeywordsFixed Dose Oral Hypoglycemic Agent Coronary Drug Project Inical Trial Lower Serum Lipid
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
© Springer Science+Business Media New York 1972